Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia

    Yu-Hung Wang, Chien-Chin Lin, Kristian Gurashi, Chi-Yuan Yao in Blood Cancer Journal (2024)

  2. Article

    Open Access

    In situ HER2 RNA expression as a predictor of pathologic complete response of HER2-positive breast cancer patients receiving neoadjuvant chemotherapy and anti-HER2 targeted treatment

    Immunohistochemistry (IHC) and in situ hybridization (ISH) remain standard biomarkers for therapeutic decisions in human epidermal growth factor 2 (HER2)-positive breast cancers (BCs); however, they are insuff...

    Huang-Chun Lien, Chiao Lo, Yi-Hsuang Lee, Po-Hang Lin in Breast Cancer Research (2024)

  3. Article

    Open Access

    The associates of anxiety among lung cancer patients: Dehydroepiandrosterone (DHEA) as a potential biomarker

    Anxiety is a prevalent comorbidity in lung cancer (LC) patients associated with a decline in quality of life. Dehydroepiandrosterone (DHEA), a neuroactive steroid, levels rise in response to stress. Prior rese...

    Jia-Rong Wu, Vincent Chin -Hung Chen, Yu-Hung Fang, Ching-Chuan Hsieh in BMC Cancer (2024)

  4. Article

    Open Access

    The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study

    The irreversible epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) afatinib and dacomitinib are approved for first-line treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC)...

    Wen-Chien Cheng, Chi-Chien Lin, Wei-Chih Liao, Yu-Chao Lin, Chia-Hung Chen in BMC Cancer (2024)

  5. Article

    Open Access

    A novel computer-assisted tool for 3D imaging of programmed death-ligand 1 expression in immunofluorescence-stained and optically cleared breast cancer specimens

    Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) are the two most common immune checkpoints targeted in triple-negative breast cancer (BC). Refining patient selection for immunotherapy is non-tr...

    Yi-Hsuan Lee, Chung-Yen Huang, Yu-Han Hsieh, Chia-Hung Yang, Yu-Ling Hung in BMC Cancer (2024)

  6. Article

    Open Access

    Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia

    Acute myeloid leukemia (AML) is a fast-growing and highly fatal blood cancer, and recent research has shown that targeting metabolism may be a promising therapeutic approach for treating AML. One promising tar...

    Kun-Chi Chen, I-Hsin Hsiao, Yu-Nan Huang, Yu-Tung Chou, Yi-Chun Lin in Cellular Oncology (2023)

  7. No Access

    Article

    Soluble CD137 and risk of hepatocellular carcinoma: nested case–control studies in cohorts in Shanghai and Singapore

    The majority of hepatocellular carcinoma (HCC) cases occur in the presence of cirrhosis. Biomarkers of cirrhosis-associated immune dysfunction such as CD8+ T cell cytokines could aid HCC risk assessment.

    Claire E. Thomas, Jennifer J. Adibi, Allison L. Kuipers in British Journal of Cancer (2023)

  8. Article

    Open Access

    Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery

    Artificial intelligence-based tools can be leveraged to improve detection and segmentation of brain metastases for stereotactic radiosurgery (SRS). VBrain by Vysioneer Inc. is a deep learning algorithm with re...

    Jen-Yeu Wang, Vera Qu, Caressa Hui, Navjot Sandhu, Maria G. Mendoza in Radiation Oncology (2023)

  9. Article

    Open Access

    Clinical impact of tetracyclines and/or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: a retrospective cohort study

    This retrospective cohort study examined the impact of tetracyclines (TCs) and proton pump inhibitors (PPIs) alone or in combination on the efficacy of epidermal growth factor receptor tyrosine kinase inhibito...

    Hui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, Yu-Hung Kuo, Mann-Jen Hour in BMC Cancer (2023)

  10. Article

    Open Access

    Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study

    The prognostic significance of the relapse interval in patients with resected oral cavity squamous cell carcinoma (OCSCC) is a matter of ongoing debate. In this large-scale, registry-based, nationwide study, w...

    Chi-Ying Tsai, Yu-Wen Wen, Shu-Ru Lee, Shu-Hang Ng, Chung-Jan Kang, Li-Yu Lee in BMC Cancer (2023)

  11. Article

    Open Access

    Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma

    Metaplastic breast carcinoma (MpBC) typically consists of carcinoma of no special type (NST) with various metaplastic components. Although previous transcriptomic and proteomic studies have reported subtype-re...

    Huang-Chun Lien, Chia-Lang Hsu, Yen-Shen Lu, Tom Wei-Wu Chen in Breast Cancer Research (2023)

  12. Article

    Open Access

    A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapy

    The applicability and therapeutic efficacy of specific personalized immunotherapy for cancer patients is limited by the genetic diversity of the host or the tumor. Side-effects such as immune-related adverse e...

    Chia-Hung Chen, Tzu-Han Weng in Journal of Experimental & Clinical Cancer … (2023)

  13. Article

    Open Access

    CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer

    Colorectal cancer (CRC), the most common cancer type, causes high morbidity and mortality. Patients who develop drug resistance to oxaliplatin-based regimens have short overall survival. Thus, identifying mole...

    Chi-Che Hsieh, Sen-Huei Hsu, Chih-Yu Lin, Hung-Jiun Liaw in British Journal of Cancer (2022)

  14. Article

    Open Access

    Female breast cancer incidence predisposing risk factors identification using nationwide big data: a matched nested case-control study in Taiwan

    Breast cancer is an umbrella term referring to a group of biologically and molecularly heterogeneous diseases originating from the breast. Globally, incidences of breast cancer has been increasing dramatically...

    **-Hung Liu, James Cheng-Chung Wei, Yu-Hsun Wang, Ming-Hsin Yeh in BMC Cancer (2022)

  15. Article

    Open Access

    EV-miRome-wide profiling uncovers miR-320c for detecting metastatic colorectal cancer and monitoring the therapeutic response

    Molecular composition of circulating small extracellular vesicles (EVs) does not merely reflect the cells of origin, but also is enriched in specific biomolecules directly associated with the cellular transfor...

    Chan-Keng Yang, Hung-Chih Hsu, Yu-Hao Liu, Wen-Sy Tsai, Chung-Pei Ma in Cellular Oncology (2022)

  16. Article

    Open Access

    Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma

    Annexin A10 expression influences the prognosis of several gastrointestinal cancers. We explored the association of annexin A10 expression with the overall survival (OS) of patients who underwent curative surg...

    Yu-Yun Shao, Hung-Yang Kuo, Yung-Ming Jeng, Yao-Ming Wu, Hsiu-Po Wang in BMC Cancer (2022)

  17. Article

    Open Access

    Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study

    Vascular endothelial growth factor (VEGF) plays a role in the tumor microenvironment. Sorafenib, which inhibits the VEGF pathway, has an immune-modulation function but lacks substantial clinical data. This stu...

    San-Chi Chen, Yi-Hsiang Huang, Ming-Huang Chen, Yi-** Hung, Rheun-Chuan Lee in BMC Cancer (2022)

  18. Article

    Open Access

    The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study

    Studies have indicated that individuals taking aspirin have a reduced risk of cancers and have also established chemo-preventive benefit of aspirin in colorectal cancer. However, research on the association be...

    Min-Chun Chuang, Yao-Hsu Yang, Meng-Jer Hsieh, Yu-Ching Lin, Tsung-Ming Yang in BMC Cancer (2021)

  19. Article

    Open Access

    Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection

    Autophagy-related proteins may predict postresection overall survival (OS) and disease-free survival (DFS) in patients with combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC).

    Daw-Shyong Perng, Chao-Ming Hung, Hung-Yu Lin, Paul Morgan, Yao-Chun Hsu in BMC Cancer (2021)

  20. Article

    Open Access

    High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer

    Existence of breast cancer stem cells (BCSCs) is implicated in disease relapse, metastasis, and resistance of treatment. β1,3-Galactosyltransferase 5 (B3GALT5) has been shown to be a pro-survival marker for BC...

    Yu-Mei Liao, Ya-Hui Wang, Jung-Tung Hung, Yu-Ju Lin in Breast Cancer Research (2021)

previous disabled Page of 3